Your browser doesn't support javascript.
loading
Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19-Results From a Pilot Open-Label, Randomized Controlled Trial.
Khan, Amjad; Iqtadar, Somia; Mumtaz, Sami Ullah; Heinrich, Michael; Pascual-Figal, Domingo A; Livingstone, Shona; Abaidullah, Sajid.
Affiliation
  • Khan A; INEOS Oxford Institute for AMR Research, University of Oxford, Oxford, United Kingdom.
  • Iqtadar S; Department of Biochemistry, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan.
  • Mumtaz SU; Department of Medicine, King Edward Medical University, Lahore, Pakistan.
  • Heinrich M; Department of Medicine, King Edward Medical University, Lahore, Pakistan.
  • Pascual-Figal DA; UCL School of Pharmacy, University of London, London, United Kingdom.
  • Livingstone S; Department of Cardiology, University of Murcia Hospital Universitario Virgen de la Arrixaca Murcia, Murcia, Spain.
  • Abaidullah S; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Front Pharmacol ; 13: 898062, 2022.
Article in En | MEDLINE | ID: mdl-35747751
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Plantas_medicinales Type of study: Clinical_trials / Diagnostic_studies Language: En Journal: Front Pharmacol Year: 2022 Type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Plantas_medicinales Type of study: Clinical_trials / Diagnostic_studies Language: En Journal: Front Pharmacol Year: 2022 Type: Article Affiliation country: United kingdom